Skip to main content
Journal of Translational Medicine logoLink to Journal of Translational Medicine
. 2024 Jan 4;22:20. doi: 10.1186/s12967-023-04697-0

Correction: YangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells

Wen G Jiang 1,, Lin Ye 1, Fiona Ruge 1, Sioned Owen 1, Tracey Martin 1, Ping‑Hui Sun 1, Andrew J Sanders 1, Jane Lane 1, Lucy Satherley 1, Hoi P Weeks 1, Yong Gao 2, Cong Wei 2, Yiling Wu 2, Malcolm D Mason 1
PMCID: PMC10768227  PMID: 38178184

Correction: J Transl Med (2015) 13:280 https://doi.org/10.1186/s12967-015-0639-1

Following publication of the original article [1], we have been notified that the conflict of interest declaration was incomplete. Co-authors Dr Y Gao, Dr C Wei and Dr Y Wu are employees of Yiling Medical Research Institute, a subsidiary research organisation of Yiling Pharmaceuticals and therefore are employees of Yiling Pharmaceuticals.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Jiang WG, Ye L, Ruge F, Owen S, Martin T, Sun PH, Sanders AJ, Lane J, Satherley L, Weeks HP, Gao Y, Wei C, Wu Y, Mason MD. Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis. J Transl Med. 2015;13:280. doi: 10.1186/s12967-015-0639-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Translational Medicine are provided here courtesy of BMC

RESOURCES